Notably, the presence of FLT3-ITD did not seem to have a negative impact on survival in t-AML (perhaps due to their low frequency), while NPM1-mutated t-AML carried significantly better survival rates than NPM1 wild-type t-AML. This evidence concerns the gene FLT3 and acute myeloid leukemia.